Get the Stockscreener App
4.32
10.49%
0.41
Engene Holdings Inc stock is traded at $4.32, with a volume of 120.69K.
It is up +10.49% in the last 24 hours and up +11.92% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$3.91
Open:
$3.97
24h Volume:
120.69K
Relative Volume:
1.49
Market Cap:
$220.77M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-0.9391
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+17.39%
1M Performance:
+11.92%
6M Performance:
-31.32%
1Y Performance:
-28.71%
1-Day Range:
$3.9401
$4.40
1-Week Range:
$3.64
$4.40
52-Week Range:
$2.65
$11.00
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
4.32 | 190.11M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
When is the best time to exit enGene Holdings Inc.Trade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Published on: 2025-08-21 01:29:22 - newsyoung.net
Can machine learning forecast enGene Holdings Inc. Equity Warrant recoveryMarket Risk Analysis & AI Driven Price Predictions - Newser
Signal strength of enGene Holdings Inc. Equity Warrant stock in tech scannersGold Moves & Expert Approved Trade Ideas - Newser
Multi factor analysis applied to enGene Holdings Inc.2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Applying Wyckoff theory to enGene Holdings Inc. Equity Warrant stockTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Is enGene Holdings Inc. Equity Warrant meeting your algorithmic filter criteriaWeekly Trend Summary & AI Enhanced Market Trend Forecasts - Newser
Is enGene Holdings Inc. stock reversal real or fakeJuly 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Can technical indicators confirm enGene Holdings Inc. Equity Warrant’s reversal2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Identifying reversal signals in enGene Holdings Inc. Equity Warrant2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser
Visual analytics tools that track enGene Holdings Inc. Equity Warrant performanceTrade Risk Summary & Weekly High Potential Stock Alerts - Newser
What indicators show strength in enGene Holdings Inc.July 2025 Volume & Consistent Profit Trading Strategies - Newser
Multi asset correlation models including enGene Holdings Inc.Trade Signal Summary & Long-Term Safe Investment Plans - Newser
How to escape a deep drawdown in enGene Holdings Inc.July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
Trend analysis for enGene Holdings Inc. Equity Warrant this weekEarnings Miss & Low Risk High Reward Ideas - Newser
How institutional ownership impacts enGene Holdings Inc. Equity Warrant stockJuly 2025 Decliners & Momentum Based Trading Signals - Newser
Custom watchlist performance reports with enGene Holdings Inc.Trade Signal Summary & Verified Stock Trade Ideas - Newser
enGene Holdings Inc. stock trendline breakdownEarnings Growth Report & Low Risk Entry Point Guides - Newser
Should you wait for a breakout in enGene Holdings IncTrade Analysis Report & Expert Approved Momentum Ideas - Newser
What technical models suggest about enGene Holdings Inc.’s comebackGap Down & Entry and Exit Point Strategies - Newser
Tools to monitor enGene Holdings Inc. recovery probabilityJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Volume spikes in enGene Holdings Inc. Equity Warrant stock – what they mean2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Building trade automation scripts for enGene Holdings Inc.2025 Analyst Calls & AI Driven Price Predictions - Newser
Is enGene Holdings Inc. still worth holding after the dipTrade Volume Report & AI Powered Buy/Sell Recommendations - Newser
Should you wait for a breakout in enGene Holdings Inc.Weekly Stock Analysis & Risk Managed Investment Strategies - Newser
How to use a screener to detect enGene Holdings Inc. breakoutsPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
Using portfolio simulators with enGene Holdings Inc. Equity Warrant includedJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - Newser
Can enGene Holdings Inc. Equity Warrant recover in the next quarterMarket Performance Report & Real-Time Buy Zone Alerts - Newser
Earnings visualization tools for enGene Holdings Inc.2025 Investor Takeaways & Daily Entry Point Trade Alerts - Newser
Forecasting enGene Holdings Inc. price range with options dataGap Down & Long-Term Capital Growth Strategies - Newser
This enGene Holdings Insider Increased Their Holding In The Last Year - Yahoo Finance
Will enGene Holdings Inc. Equity Warrant rebound enough to break evenJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
What does recent volatility data suggest for enGene Holdings Inc.Bond Market & AI Forecasted Entry and Exit Points - Newser
What the charts say about enGene Holdings Inc. todayQuarterly Profit Review & Real-Time Buy Signal Notifications - Newser
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Engene Holdings Inc Stock (ENGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
| Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 08 '24 |
Buy |
6.60 |
800 |
5,278 |
2,470,633 |
| Cooper Ronald Harold Wilfred | Chief Executive Officer |
Sep 27 '24 |
Buy |
5.70 |
10,000 |
57,000 |
10,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):